Molecular Oncology
Volume 2, Issue 1 , Pages 33-40 , June 2008

Epigenetics and cancer, 2nd IARC meeting, Lyon, France, 6 and 7 December 2007

Received 28 February 2008 ,Revised 14 March 2008 ,Accepted 17 March 2008.

References 

  1. Akiyama Y, Watkins N, Suzuki H, Jair KW, van Engeland M, Esteller M, et al GATA-4 and GATA-5 transcription factor genes and potential downstream antitumor target genes are epigenetically silenced in colorectal and gastric cancer. Molecular and Cellular Biology. 2003;23:8429–8439
  2. Baylin SB. DNA methylation and gene silencing in cancer. Nature Clinical Practice Oncology. 2005;2(Suppl. 1):S4–S11
  3. Bird A. DNA methylation patterns and epigenetic memory. Genes and Development. 2002;16:6–21
  4. Calin GA, Croce CM. MicroRNA signatures in human cancers. Nature Reviews. 2006;6:857–866
  5. Callinan PA, Feinberg AP. The emerging science of epigenomics. Human Molecular Genetics. 2006;15(Spec No. 1):R95–R101
  6. Carrozza MJ, Utley RT, Workman JL, Cote J. The diverse functions of histone acetyltransferase complexes. Trends in Genetics. 2003;19:321–329
  7. Delaval K, Feil R. Epigenetic regulation of mammalian genomic imprinting. Current Opinion in Genetics and Development. 2004;14:188–195
  8. Delaval K, Govin J, Cerqueira F, Rousseaux S, Khochbin S, Feil R. Differential histone modifications mark mouse imprinting control regions during spermatogenesis. The Embo Journal. 2007;26:720–729
  9. Eckhardt F, Lewin J, Cortese R, Rakyan VK, Attwood J, Burger M, et al DNA methylation profiling of human chromosomes 6, 20 and 22. Nature Genetics. 2006;38:1378–1385
  10. Esteller M. Cancer epigenomics: DNA methylomes and histone-modification maps. Nature Reviews Genetics. 2007;8:286–298
  11. Feinberg AP, Ohlsson R, Henikoff S. The epigenetic progenitor origin of human cancer. Nature Reviews Genetics. 2006;7:21–33
  12. Feinberg AP, Tycko B. The history of cancer epigenetics. Nature Reviews. 2004;4:143–153
  13. Fournier C, Goto Y, Ballestar E, Delaval K, Hever AM, Esteller M, et al. Allele-specific histone lysine methylation marks regulatory regions at imprinted mouse genes. The Embo Journal. 2002;21:6560–6570
  14. Hitchins MP, Wong JJ, Suthers G, Suter CM, Martin DI, Hawkins NJ, et al. Inheritance of a cancer-associated MLH1 germ-line epimutation. The New England Journal of Medicine. 2007;356:697–705
  15. Jaenisch R, Bird A. Epigenetic regulation of gene expression: how the genome integrates intrinsic and environmental signals. Nature Genetics. 2003;33(Suppl.):245–254
  16. Jenuwein T, Allis CD. Translating the histone code. Science. 2001;293:1074–1080(New York, NY)
  17. Murr R, Vaissiere T, Sawan C, Shukla V, Herceg Z. Orchestration of chromatin-based processes: mind the TRRAP. Oncogene. 2007;26:5358–5372
  18. Murrell A, Rakyan VK, Beck S. From genome to epigenome. Human Molecular Genetics. 2005;14(Spec No. 1):R3–R10
  19. Pannetier M, Feil R. Epigenetic stability of embryonic stem cells and developmental potential. Trends in Biotechnology. 2007;25:556–562
  20. Rauch T, Li H, Wu X, Pfeifer GP. MIRA-assisted microarray analysis, a new technology for the determination of DNA methylation patterns, identifies frequent methylation of homeodomain-containing genes in lung cancer cells. Cancer Research. 2006;66:7939–7947
  21. Raval A, Tanner SM, Byrd JC, Angerman EB, Perko JD, Chen SS, et al Downregulation of death-associated protein kinase 1 (DAPK1) in chronic lymphocytic leukemia. Cell. 2007;129:879–890
  22. Roberts CW, Orkin SH. The SWI/SNF complex – chromatin and cancer. Nature Reviews. 2004;4:133–142
  23. Rountree MR, Bachman KE, Herman JG, Baylin SB. DNA methylation, chromatin inheritance, and cancer. Oncogene. 2001;20:3156–3165
  24. Schlesinger Y, Straussman R, Keshet I, Farkash S, Hecht M, Zimmerman J, et al Polycomb-mediated methylation on Lys27 of histone H3 pre-marks genes for de novo methylation in cancer. Nature Genetics. 2007;39:232–236
  25. Shen L, Toyota M, Kondo Y, Lin E, Zhang L, Guo Y, et al Integrated genetic and epigenetic analysis identifies three different subclasses of colon cancer. Proceedings of the National Academy of Sciences of the United States of America. 2007;104:18654–18659
  26. Strahl BD, Allis CD. The language of covalent histone modifications. Nature. 2000;403:41–45
  27. Toyota M, Ahuja N, Ohe-Toyota M, Herman JG, Baylin SB, Issa JP. CpG island methylator phenotype in colorectal cancer. Proceedings of the National Academy of Sciences of the United States of America. 1999;96:8681–8686
  28. Umlauf D, Goto Y, Cao R, Cerqueira F, Wagschal A, Zhang Y, et al. Imprinting along the Kcnq1 domain on mouse chromosome 7 involves repressive histone methylation and recruitment of Polycomb group complexes. Nature Genetics. 2004;36:1296–1300
  29. Valk PJ, Verhaak RG, Beijen MA, Erpelinck CA, Barjesteh van Waalwijk van Doorn-Khosrovani S, Boer JM, et al Prognostically useful gene-expression profiles in acute myeloid leukemia. The New England Journal of Medicine. 2004;350:1617–1628
  30. Volinia S, Calin GA, Liu CG, Ambs S, Cimmino A, Petrocca F, et al A microRNA expression signature of human solid tumors defines cancer gene targets. Proceedings of the National Academy of Sciences of the United States of America. 2006;103:2257–2261
  31. Wagschal A, Sutherland HG, Woodfine K, Henckel A, Chebli K, Schulz R, et al. G9a histone methyltransferase contributes to imprinting in the mouse placenta. Molecular and Cellular Biology. 2008;28:1104–1113
  32. Weber M, Hellmann I, Stadler MB, Ramos L, Paabo S, Rebhan M, et al. Distribution, silencing potential and evolutionary impact of promoter DNA methylation in the human genome. Nature Genetics. 2007;39:457–466
  33. Widschwendter M, Menon U. Circulating methylated DNA: a new generation of tumor markers. Clinical Cancer Research. 2006;12:7205–7208
  34. Yuan E, Haghighi F, White S, Costa R, McMinn J, Chun K, et al. A single nucleotide polymorphism chip-based method for combined genetic and epigenetic profiling: validation in decitabine therapy and tumor/normal comparisons. Cancer Research. 2006;66:3443–3451

☆ Meeting participants: Stephan Beck (UCL Cancer Institute, University College London, UK), Haim J. Bendayan (Hôpital Pitié Salpêtrière, Paris, France), Manon van Engeland (Maastricht University, the Netherlands), Robert Feil (Institute of Molecular Genetics, University of Montpellier, France), Zdenko Herceg (International Agency for Research on Cancer, France), Triantafillos Liloglou (University of Liverpool, UK), Gerd Pfeifer (City of Hope National Medical Center, USA), Dirk Schübeler (Friedrich Miescher Institute, Switzerland), Minoru Toyota (Sapporo Medical University, Japan), Benjamin Tycko (Columbia University, USA), Mukesh Verma (National Cancer Institute, NIH, USA), Robyn Ward (University of Sydney, Australia).

PII: S1574-7891(08)00038-0

doi: 10.1016/j.molonc.2008.03.005

Molecular Oncology
Volume 2, Issue 1 , Pages 33-40 , June 2008

Article Tools

* Image Usage & Resolution